Antony C. Mattessich has bought OCUL on 5 days since Dec 2017
President and CEO at Ocular Therapeutix, Inc.
SEC CIK 0001709900 · Filings on SEC.gov ↗
$476KBought
$270KSold
Aug 24Last buy
Antony C. Mattessich's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
8 filings since Dec 2017, newest first
OCULSell
Ocular Therapeutix, Inc
President and CEO
$95K−3.0%Feb 6
OCULSell
Ocular Therapeutix, Inc
President and CEO
$91K−4.0%Feb 2
OCULSell
Ocular Therapeutix, Inc
President and CEO
$83K−4.0%Feb 8
OCULBuy
Ocular Therapeutix, Inc
President and CEO
$49K+5.0%Aug 24
OCULBuy
Ocular Therapeutix, Inc
President and CEO
$112K+69.0%Jun 10
OCULBuy
Ocular Therapeutix, Inc
President and CEO
$119K+53.0%Aug 21
OCULBuy
Ocular Therapeutix, Inc
President and CEO
$105K+80.0%Aug 13
OCULBuy
Ocular Therapeutix, Inc
Pres, C.E.O.
$90KDec 13
Filings come from SEC EDGAR. Not investment advice.